Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bekesi

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|November 10, 1983
Immune competence in Haitians living in New YorkP Nicholas, J Masci, J deCatalogne, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
3-Bromoacetylamino benzoylurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematologyJ D Jiang, Y Wang, C A Janish, et al.
The Journal of Surgical Research|April 1, 1980
Effects of thymectomy on mammary tumor growthG Peer, A E Papatestas, P Tartter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcomaP J Houghton, R Tharp, J A Houghton, et al.
Journal of the National Cancer Institute|March 1, 1986
Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agentM J Yagi, F Maldarelli, S E Chin, et al.
Archives of Neurology|March 1, 1991
Quantitative neurologic and neurobehavioral testing of persons infected with human immunodeficiency virus type 1A Franzblau, R Letz, D Hershman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1986
Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD)M Shafir, G Martinelli, J G Bekesi, et al.
Journal of Immunological Methods|January 1, 1980
Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinomaP H Tsang, K Tangnavarad, G Lesnick, et al.
Biochemical Pharmacology|July 1, 1985
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell linesM J Yagi, S E Chin, K J Scanlon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicityM J Yagi, J G Bekesi, M D Daniel, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|November 10, 1983
Immune competence in Haitians living in New YorkP Nicholas, J Masci, J deCatalogne, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 1998
3-Bromoacetylamino benzoylurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematologyJ D Jiang, Y Wang, C A Janish, et al.
The Journal of Surgical Research|April 1, 1980
Effects of thymectomy on mammary tumor growthG Peer, A E Papatestas, P Tartter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcomaP J Houghton, R Tharp, J A Houghton, et al.
Journal of the National Cancer Institute|March 1, 1986
Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agentM J Yagi, F Maldarelli, S E Chin, et al.
Archives of Neurology|March 1, 1991
Quantitative neurologic and neurobehavioral testing of persons infected with human immunodeficiency virus type 1A Franzblau, R Letz, D Hershman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1986
Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD)M Shafir, G Martinelli, J G Bekesi, et al.
Journal of Immunological Methods|January 1, 1980
Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinomaP H Tsang, K Tangnavarad, G Lesnick, et al.
Biochemical Pharmacology|July 1, 1985
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell linesM J Yagi, S E Chin, K J Scanlon, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicityM J Yagi, J G Bekesi, M D Daniel, et al.
Pageof 13